Faeth Therapeutics (FTH) Accumulated Depreciation (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Accumulated Depreciation came in at $581000.0 in Q1 2026, up 29.69% YoY from $448000.0 in Q1 2025, and up 7.59% on a QoQ basis from $540000.0 in Q4 2025.
Faeth Therapeutics (FTH) Accumulated Depreciation (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Accumulated Depreciation data on file, last reported at $581000.0 in Q1 2026.
- Quarterly Accumulated Depreciation rose 29.69% year-over-year to $581000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $581000.0 (up 29.69% YoY) and the FY2025 annual result came in at $540000.0, down 63.9% from the prior year.
- Accumulated Depreciation advanced to $581000.0 in Q1 2026, from $540000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $2.1 million in Q3 2024 to a low of $448000.0 in Q1 2025.
- A 5-year average of $1.3 million and a median of $1.5 million in 2022 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2022 — Accumulated Depreciation surged 100.27% — and 2025, when it plunged 76.16%.
- Tracing FTH's Accumulated Depreciation over 5 years: stood at $1.4 million in 2022, then climbed by 19.68% to $1.7 million in 2023, then declined by 13.38% to $1.5 million in 2024, then plunged by 63.9% to $540000.0 in 2025, then gained by 7.59% to $581000.0 in 2026.
- The last three Accumulated Depreciation figures came in at $581000.0 (Q1 2026), $540000.0 (Q4 2025), and $510000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 606,000.00 |
| Mar 31, 2026 | 581,000.00 |
| Dec 31, 2025 | 540,000.00 |
| Sep 30, 2025 | 510,000.00 |
| Jun 30, 2025 | 480,000.00 |
| Mar 31, 2025 | 448,000.00 |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 879,000.00 |